A Multicentre, Prospective, Randomized, Open-label, Blinded Endpoint, Pilot Clinical Trial Evaluating Subcutaneous Semaglutide in Patients With Acute Ischaemic Stroke Due to Anterior Circulation Large Vessel Occlusion Treated With Endovascular Thrombectomy
Latest Information Update: 09 Apr 2026
At a glance
- Drugs Semaglutide (Primary)
- Indications Ischaemic stroke
- Focus Therapeutic Use
- Acronyms LEAST
Most Recent Events
- 09 Apr 2026 New trial record